SCHEMBL9709026

SCHEMBL9709026

Cn1c(=O)[nH]c2nc(C3CCCCC3)n(Cc3ccc(-c4ccccc4)c(-c4nnn[nH]4)c3)c2c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.43
POLB P06746 2/20 0.37
MEN1 O00255 2/20 0.37
RAB9A P51151 1/20 0.37
AGTR1 P30556 3/20 0.36
AGTR2 P50052 3/20 0.36
MAPK1 P28482 2/20 0.35
TP53 P04637 1/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
BLM P54132 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CTDSP1 Q9GZU7 1/20 0.35
DPP4 P27487 1/20 0.34
ADORA2A P29274 1/20 0.34
ADORA2B P29275 1/20 0.34
GPR18 Q14330 1/20 0.34
ADORA3 P0DMS8 2/20 0.33
KDM4C Q9H3R0 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9707463 0.91 KMT2A (0.45) KMT2APOLBMEN1RAB9AAGTR1
SCHEMBL9708115 0.84 KMT2A (0.42) KMT2APOLBMEN1RAB9AAGTR1
SCHEMBL9708761 0.83 ADORA3 (0.43) KMT2AAGTR1AGTR2ADORA2AADORA2B
SCHEMBL9707737 0.83 KMT2A (0.43) KMT2APOLBMEN1RAB9AAGTR1
SCHEMBL9708395 0.83 KMT2A (0.42) KMT2AAGTR1AGTR2ADORA2AADORA2B
SCHEMBL9844993 0.83 ALDH1A1 (0.44) KMT2AMEN1MAPK1TP53TSHR
SCHEMBL9707731 0.82 AGTR1 (0.41) KMT2AMEN1AGTR1AGTR2KDM4E
SCHEMBL9708511 0.81 KMT2A (0.41) KMT2APOLBMEN1RAB9AAGTR1
SCHEMBL9707895 0.81 KMT2A (0.41) KMT2AMEN1AGTR1AGTR2ADORA2B
SCHEMBL9707300 0.81 AGTR1 (0.39) KMT2AAGTR1AGTR2GPR18

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed